2015 Fall NCI CTEP Early Drug Development Meeting
Date: Monday, 10 05, 2015; Speaker: Fatima Karzai, NCI CCR; Missak Haigentz, Albert Einstein; Manisha Shah, Ohio State University; Manisha Shah, Ohio State University; Joel Neal, Stanford University; Ursula Matulonis, Dana-Farber Cancer Institute; Alison Walker, Ohio State University; Susan Bates , CCR, NCI ; Tanya Siddiqi, City of Hope; Maha Hussain, University of Michigan ; Brenda Weigel, University of Minnesota; Giorgio Trinchieri, CCR, NCI; Sandra D’Angelo, Memorial Sloan-Kettering Cancer Center; Stephanie Lheureux, Princess Margaret ; Matthew Davids, Dana-Farber Cancer Institute; Paul Nghiem, Seattle Cancer Care Al...
Source: NIH Calendar of Events - September 1, 2015 Category: American Health Source Type: events
CTEP Early Drug Development (EDD) Meeting
Date: Monday, 10 05, 2015; Speaker: Fatima Karzai, NCI CCR; Missak Haigentz, Albert Einstein; Manisha Shah, Ohio State University; Manisha Shah, Ohio State University; Joel Neal, Stanford University; Ursula Matulonis, Dana-Farber Cancer Institute; Alison Walker, Ohio State University; Susan Bates , CCR, NCI ; Tanya Siddiqi, City of Hope; Maha Hussain, University of Michigan ; Brenda Weigel, University of Minnesota; Giorgio Trinchieri, CCR, NCI; Sandra D’Angelo, Memorial Sloan-Kettering Cancer Center; Stephanie Lheureux, Princess Margaret ; Matthew Davids, Dana-Farber Cancer Institute; Paul Nghiem, Seattle Cancer Care Al...
Source: NIH Calendar of Events - August 27, 2015 Category: American Health Source Type: events
Biomarkers: Advanced Topics
2015-09-10
2015-09-10
To explore recent advances in biomarker development for kidney function, drug-drug interaction, cardiovascular disease, microRNA 155 and exosomes in toxicity, non-alcoholic steatohepatitus (NASH), and drug-metabolizing enzymes and transporter (Source: AAPS Calendar)
Source: AAPS Calendar - August 4, 2015 Category: Drugs & Pharmacology Source Type: events
Different Paths from Bench to Bedside: Acetaminophen Toxicity and Hepatorenal Syndrome
Date: Monday, 04 20, 2015; Speaker: Dr. Thomas Boyer, Professor of Medicine, Univesity of Arizona; Building: Building 45 (Natcher Building); Balcony B (Source: NIH Calendar of Events)
Source: NIH Calendar of Events - March 20, 2015 Category: American Health Source Type: events
Tuesday, March 3, 2015 -- Research Directions in Genetically-Mediated Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
The objectives of the workshop are to:
1. Review current state of knowledge of surveillance, pathogenesis, and treatment of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN)
2. Examine role of genomics and pharmacogenomics in etiology, treatment, and eradication of preventable causes of drug-induced SJS/TEN
3. Identify gaps, unmet needs, and priorities for future research to eliminate genetically mediated SJS/TEN globallyLocation: Building 31, Conference Center (6th floor of 31C)Start: March 03, 2015 @ 08:00 AMEnd: March 04, 2015 @ 03:00 PM (Source: NHGRI Events)
Source: NHGRI Events - February 25, 2015 Category: Genetics & Stem Cells Source Type: events
Single-vesicle Fusion Assays for the Toxic Effect of a-synuclein Oligomers and Observing Fusion Pore Dynamics
Date: Thursday, 02 05, 2015; Speaker: Nam Ki Lee, PhD, Pohang University of Science and Technology; Building: Building 5; Room 127 (Source: NIH Calendar of Events)
Source: NIH Calendar of Events - January 31, 2015 Category: American Health Source Type: events
CC Grand Rounds: Clinicopathologic Grand Rounds: Clinical Cases from the NIH Clinical Center: Recombinant Anti-CD22 Immunotoxin Therapy of Drug-Resistant Hairy Cell Leukemia: Eradication of Minimal Residual Disease Without Chemotherapy Toxicity
Date: Wednesday, 02 18, 2015; Speaker: Ira Pastan, MD , Co-Chief, Laboratory of Molecular Biology, NCI; Robert J. Kreitman, MD , Chief, Clinical Immunotherapy Section, Laboratory of Molecular Biology, NCI; Building: Building 10 (Clinical Center); Lipsett Amphitheater; CME Credit; Videocast Event (Source: NIH Calendar of Events)
Source: NIH Calendar of Events - January 23, 2015 Category: American Health Source Type: events
Workshop: Methods and Techniques for Integrating the Biological Variable Sex in Preclinical Research
Date: Monday, 10 20, 2014; Speaker: Lawrence Tabak, D.D.S., Ph.D., Principal Deputy Director, National Institutes of Health; Lawrence Cahill, Ph.D. , Professor, Neurobiology and Behavior, U. of California, Irvine; Londa Schiebinger, Ph.D., M.A., The John L. Hinds Professor of History of Science, Stanford University; Cheryl Marks, Ph.D., Division of Cancer Biology Associate Director, National Cancer Institute; Jill Becker, Ph.D., Patricia Y. Gurin Collegiate Professor of Psychology, University of Michigan; Patricia Hurn, Ph.D., Vice Chancellor for Research and Innovation, The University of Texas System; Wei-Jung Andrew Chen...
Source: NIH Calendar of Events - October 27, 2014 Category: American Health Source Type: events
Pre-Filled Syringes Americas
Over 85 delegates from the world’s leading Pharma & Biotechnology businesses will meet to discuss the latest achievements in the pre-filled syringe marketplace and developments in drug stabilisation.
After a great success of European Pre-Filled Syringes events hosted in London in 2007-2013, the SMi Group is delighted to announce the launch of the Pre-Filled Syringes Conference in New Jersey, USA, in March 2014. Registration is now open.
Find out how to navigate the regulatory roadmap and deliver your product to market through efficient supply chain management with 3 days of interactive presentations, panels, networki...
Source: Nature Network London - Upcoming Events - November 29, 2013 Category: Science Source Type: events
Predictive Toxicology Summit
Applying in silico, in vitro and in vivo models to mitigate clinical failure.
As demonstrated by Vioxx and Exanta, failing to identify adverse effects of new drugs can be financially devestating. With budget cuts hitting the R&D field hard, ensuring candidate compounds are safe is even more important to reduce late stage attrition and product withdrawals.
But how do we cost-effectively develop and implement these in silico, in vitro and in vivo methods as early in drug discovery and development as possible? How do we demonstrate the validation of these methods?
Venue: IQPC
Start date: Mon, 24 Feb 2014 09:00:00...
Source: Nature Network London - Upcoming Events - November 27, 2013 Category: Science Source Type: events
Wednesday, September 25, 2013 -- 13th International Congres of Therapeutic Drug Monitoring & Clinical Toxicology
Plenary TalkStart: September 25, 2013 @ 11:00 AMEnd: September 25, 2013 @ 12:00 PM (Source: NHGRI Events)
Source: NHGRI Events - June 13, 2013 Category: Genetics & Stem Cells Source Type: events
